Lipiget Tablet 10mg

About Lipiget Tablet 10mg

Lipiget Tablet Uses

• Primary hypercholesterolemia (high LDL cholesterol) not adequately controlled by diet alone.
• Mixed dyslipidemia including elevated triglycerides and low HDL cholesterol.
• Familial hypercholesterolemia, including heterozygous and homozygous forms.
• Prevention of cardiovascular events including heart attack and stroke in patients with diabetes, hypertension, or established cardiovascular disease.
• Secondary prevention after a heart attack to reduce the risk of another cardiac event.
• Reduction of cardiovascular risk in patients with coronary artery disease (CAD).
• Prevention of atherosclerosis progression by reducing LDL and stabilizing arterial plaque.
• Reduction of cardiovascular risk in patients with peripheral arterial disease.

Lipiget Tablet Benefits

• Atorvastatin is one of the most potent statins available, producing greater LDL reductions at equivalent doses than older statins such as Simvastatin and Pravastatin.
• Reduces LDL cholesterol by 35 to 55% depending on the dose, making it effective even in patients with severely elevated cholesterol levels.
• Lowers triglycerides and modestly raises HDL cholesterol, addressing multiple aspects of the lipid profile in a single medicine.
• Reduces the risk of heart attack, stroke, and cardiovascular procedures by 30 to 40% in high-risk patients, supported by landmark clinical trials including ASCOT-LLA and TNT.
• Once-daily dosing at any time of day improves adherence compared to statins that must be taken at night.
• Available at a very affordable price in Pakistan, making long-term preventive therapy accessible for most patients.

What Experts Say

Lipiget contains Atorvastatin, the world's most prescribed statin and one of the best-evidenced cardiovascular medicines available.

How It Works

Atorvastatin is a selective, competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme in the hepatic cholesterol biosynthesis pathway. By blocking this enzyme, Atorvastatin reduces the liver's ability to produce cholesterol. In response, liver cells upregulate their expression of LDL receptors on the cell surface, which increases the uptake of LDL cholesterol from the bloodstream. The net result is a significant reduction in circulating LDL cholesterol, the primary driver of atherosclerotic plaque formation in coronary and cerebral arteries.

Beyond Cholesterol Lowering

Atorvastatin has clinically important pleiotropic effects that extend beyond cholesterol reduction. It improves endothelial function, reduces vascular inflammation by lowering C-reactive protein (CRP), stabilizes existing arterial plaques by reducing their lipid core, and has mild antithrombotic properties. These effects contribute to its cardiovascular protective benefit independently of its LDL-lowering action, which is why statins are recommended even in patients whose LDL is not severely elevated but who carry high cardiovascular risk.

Clinical Note

Lipiget is a long-term or lifelong medicine in most patients. It must not be stopped without medical advice, as discontinuation leads to rapid rebound of cholesterol levels and loss of cardiovascular protection. Muscle pain is the most important side effect to monitor. Any unexplained muscle aching, tenderness, or weakness during treatment should be reported to a doctor immediately, as rare cases of rhabdomyolysis (severe muscle breakdown) can cause kidney failure. Liver enzymes should be measured before starting treatment and periodically thereafter.

Drug Class

• Statin (HMG-CoA Reductase Inhibitor).
• Antihyperlipidemic Agent.

Packaging and Quantity

• 1 pack contains 10 tablets (1 strip of 10).
• Available in 10mg, 20mg, and 40mg strengths.

When Not to Use Lipiget

• Known allergy or hypersensitivity to Atorvastatin or any other statin.
• Active liver disease or unexplained persistent elevation of liver enzymes (transaminases).
• Pregnancy, as Atorvastatin can harm fetal development. Women of childbearing age must use effective contraception during treatment.
• Breastfeeding, as Atorvastatin passes into breast milk.
• Concurrent use of strong CYP3A4 inhibitors such as certain antifungals and antiretrovirals that significantly raise Atorvastatin blood levels.

Lipiget Tablet 10mg formula

• Atorvastatin

Available forms

• Tablets

How to use Lipiget Tablet 10mg?

• Lipiget may be taken with or without food, at any time of day.
• The tablet should be swallowed whole with a full glass of water. It should not be crushed or chewed.
• Lipiget should be taken at the same time each day to maintain consistent blood levels.
• Grapefruit and grapefruit juice must be avoided during treatment as they inhibit Atorvastatin metabolism and significantly raise blood levels.
• Any unexplained muscle pain, weakness, or tenderness should be reported to a doctor immediately.
• The standard adult starting dose is 10mg to 20mg once daily. The dose may be increased to 40mg or 80mg under medical supervision based on lipid response and tolerability.
• The dose should not be changed or stopped without consulting a doctor. Full cholesterol-lowering effect takes 2 to 4 weeks to be measurable.

Drug Interactions

All current medicines, supplements, and herbal products must be disclosed to the prescribing doctor before starting Lipiget. Key interactions include:

• Strong CYP3A4 inhibitors such as ketoconazole, itraconazole, clarithromycin, and ritonavir: These significantly raise Atorvastatin blood levels, increasing the risk of muscle toxicity. Dose reduction or avoidance may be required.
• Ciclosporin: Concurrent use dramatically increases Atorvastatin exposure. The maximum Atorvastatin dose when combined with ciclosporin is 10mg daily.
• Gemfibrozil and other fibrates: Combining with statins increases the risk of myopathy and rhabdomyolysis. This combination should be used with extreme caution.
• Niacin (nicotinic acid) at doses above 1g daily: Increases the risk of myopathy when combined with statins.
• Digoxin: Atorvastatin can increase plasma digoxin levels. Digoxin levels should be monitored when starting or adjusting Atorvastatin.
• Warfarin: Atorvastatin may modestly enhance the anticoagulant effect of warfarin. INR should be checked when starting or stopping Atorvastatin.
• Oral contraceptives: Atorvastatin increases plasma concentrations of norethindrone and ethinyl estradiol. This should be considered when selecting a contraceptive formulation.
• Cholestyramine and colestipol: Concurrent use reduces Atorvastatin absorption. Lipiget should be taken at least 1 hour before or 4 hours after these medicines.
• Rifampicin: This strong CYP3A4 inducer reduces Atorvastatin blood levels significantly, potentially reducing its cholesterol-lowering effectiveness.

Risks and warnings

• Myopathy and rhabdomyolysis: Atorvastatin can cause muscle breakdown ranging from mild myalgia to life-threatening rhabdomyolysis. Any unexplained muscle pain or weakness during treatment must be reported to a doctor immediately. The risk is higher at higher doses and in combination with certain medicines.
• Liver toxicity: Atorvastatin can cause elevated liver enzymes and, rarely, serious liver injury. Liver function tests should be performed before starting treatment. Patients with a history of liver disease or heavy alcohol use require close monitoring.
• Pregnancy: Atorvastatin is contraindicated in pregnancy. It can cause fetal harm including structural abnormalities. Women of childbearing age must use effective contraception during treatment and must stop Lipiget immediately if pregnancy occurs.
• Diabetes risk: Long-term statin use is associated with a modest increase in the risk of developing type 2 diabetes. Blood glucose should be monitored in patients at risk. The cardiovascular benefit of statins greatly outweighs this risk in most patients.
• Cognitive effects: Memory problems and confusion have been reported with statins. These effects are generally mild and reversible after stopping the medicine.
• Alcohol: Heavy alcohol use increases the risk of liver damage during Atorvastatin therapy. Alcohol intake should be minimized throughout treatment.
• Kidney disease: Patients with severe kidney impairment should start Atorvastatin at the lowest dose and be monitored closely, as reduced kidney function increases the risk of myopathy.
• Driving and machinery: Lipiget may cause dizziness in some patients. Caution is advised when driving or operating heavy machinery if this occurs.

Lipiget Tablet Side Effects

Most patients tolerate Lipiget well at recommended doses. Side effects are uncommon and rarely severe enough to require stopping treatment.

• Muscle aches, pain, or weakness (myalgia), the most commonly reported side effect.
• Nausea or mild stomach discomfort.
• Diarrhea or constipation.
• Elevated liver enzymes on blood tests, usually without symptoms.
• Mild increases in blood glucose levels, particularly in patients at risk of diabetes.
• Memory problems or confusion, which typically resolve after stopping treatment.

Serious side effects are rare but require immediate medical attention:

• Unexplained muscle pain, tenderness, weakness, or dark colored urine, which may indicate myopathy or rhabdomyolysis, a potentially life-threatening condition.
• Yellowing of the skin or eyes, severe abdominal pain, or dark urine, which may indicate serious liver damage.
• Severe allergic reaction including facial swelling, difficulty breathing, or widespread rash.
• Peripheral neuropathy presenting as tingling or numbness in the hands or feet.

Storage Conditions

• Store at room temperature, below 30°C.
• Protect from excessive heat, light, and moisture.
• Store in the original packaging.
• Keep out of reach and sight of children.
• Do not use after the expiry date printed on the packaging.
• Do not store in the bathroom or near a kitchen sink.